細胞番号 : 細胞名
RCB5029 : NIH3T3 Flp Arl13bCerulean-Fucci2a
update : 2024/11/11
|
細胞特性(Comment:英) | Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator. |
細胞特性(日) | リサーチツール :Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator。 |
細胞特性(寄託者記述:英) | NIH/3T3 is a fibroblast cell line that was isolated from a mouse NIH/Swiss embryo. These cells were generated by a stable integration of pCDNA5-CAG-Arl13bCerulean-Fucci2a using the Flp-in system they were not cloned but are isogenic. |
細胞特性(寄託者記述:日) | |
使用条件(英) | 1) The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for publication of research papers and the BIOLOGICAL RESOURCE may not be used on humans. 2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designated by the DEPOSITOR (Dev Cell 2018 47(4):509-523.e5) is requested. 3) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR and Dr. Richard Mort of Lancaster University is requested. 4) The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. 5) The BIOLOGICAL RESOURCE may not be used for commercial purposes by the RECIPIENT. 6) The RECIPIENT may not transfer the BIOLOGICAL RESOURCE to any third parties. |
使用条件(日) | |
備考(英) | |
備考(日) | |
提供申込書類(英) |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
提供申込書類(日) |
依頼書C-0001.pdf
 
同意書(非営利学術目的)C-0003.pdf
 
同意書(営利目的)C-0003p.pdf
 
|
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください(詳細)。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
|
提供手数料 |
手数料とお支払いについてはこちらをご覧ください。 |
細胞基本情報
|
|
知的財産権 |
University of Edinburgh (UK)
|
寄託者 |
Ian, Jackson
|
樹立者 |
Ian, Jackson
|
寄託日 |
2018
|
元の細胞 |
NIH/3T3
|
クローニング(寄託者) |
No
|
動物種 |
_mouse
< Mammals
|
動物系統名 |
NIH/Swiss
|
属名 |
Mus
|
種名 |
musculus
|
性別 |
Unknown
|
齢 |
embryo
|
採取組織 |
embryo
|
細胞分類 |
transformed
|
遺伝子改変 |
recombinant
|
外来遺伝子 |
pCDNA5-CAG-Arl13bFucci2a
|
選択用添加物と濃度 |
100 μg/ml Hygromycin (Gibco)
|
遺伝子組み換えウィルスの産生 |
No
|
|
細胞寿命 |
infinite
|
細胞形態 |
fibroblast-like
|
細胞培養・検査情報
| |
寄託時情報 |
ロット情報 |
培地・試薬情報 |
培地・試薬一覧はこちらをご覧ください。 |
|
培養形態 |
Adherent cells
|
Adherent cells
|
培地 |
Dulbecco’s modified Eagle’s medium (DMEM) containing ; 10% fetal calf serum (FCS), 1% Penicillin/Streptomycin, 25 mM D-Glucose, 4 mM L-glutamine, 1 mM sodium pyruvate
|
DMEM (low glucose) + 10% FBS
|
抗生物質 |
|
Free
|
|
継代方法 |
|
0.25% Trypsin
|
|
播種細胞数 |
|
3 x 10 5 cells/60 mm dish
|
継代・培地交換頻度 |
|
Subculture : 2 times/week
|
培養最適温度 |
37
℃
|
37
℃
|
二酸化炭素濃度 |
5
%
|
5
%
|
凍結培地 |
|
Medium + 10% DMSO
|
凍結方法 |
|
Slow freezing
|
マイコプラズマ/アコレプラズマ |
|
(-)
|
動物種PCR |
|
OK
|
マウス系統検査 |
|
OK
|
文献情報 |
Reference(英) |
1件
|
Reference(日) |
0件
|
利用者成果(英) |
0件
|
利用者成果(日) |
0件
|